James Mackin to sell AORT shares (AORT) after restricted vesting

Rhea-AI Filing Summary

James Mackin reported proposed sales of common stock under a Form 144. The filing lists 20,962 shares to be sold in connection with restricted stock vesting on 02/20/2026. The filing also shows prior sales of 30,921 shares on 12/02/2025 for $1,408,736.02 and 30,921 shares on 12/03/2025 for $1,405,693.40.

Insights

Corporate Governance Expert

Routine insider sale notice tied to restricted stock vesting.

The filing lists 20,962 common shares to be sold on 02/20/2026 linked to restricted stock vesting. Prior transactions show two dispositions of 30,921 shares each on 12/02/2025 and 12/03/2025 with proceeds of $1,408,736.02 and $1,405,693.40, respectively.

These entries are typical compliance disclosures for insiders selling vested equity. Cash‑flow treatment and any broker or plan details are not specified in the excerpt; subsequent filings or broker reports would show execution details if disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	20962	787909.17	47883897	02/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2026	Restricted Stock Vesting	Issuer			20962	02/20/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Mackin 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	12/02/2025	30921	1408736.02
James Mackin 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	12/03/2025	30921	1405693.40

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does James Mackin's Form 144 for AORT report?

The Form 144 reports a proposed sale of 20,962 common shares tied to restricted stock vesting on 02/20/2026. It also discloses prior sales in December 2025 of 30,921 shares on two dates with accompanying dollar amounts.

How many shares is the filing seeking to sell and when?

The filing lists 20,962 shares to be sold in connection with restricted stock vesting on 02/20/2026. The entry is presented under the "Securities To Be Sold" row in the excerpt.

Did James Mackin recently sell any AORT shares?

Yes. The excerpt shows sales of 30,921 shares on 12/02/2025 with $1,408,736.02 and 30,921 shares on 12/03/2025 with $1,405,693.40, listed under "Securities Sold During The Past 3 Months."

Is the sale related to compensation or vesting?

The filing ties the listed sale of 20,962 shares to Restricted Stock Vesting, indicating the shares are being sold as a result of vested compensation rather than an open‑market decision described in the excerpt.

Does the excerpt state who receives sale proceeds?

The excerpt lists dollar amounts associated with past sales but does not specify the recipient of proceeds in narrative form; the rows show names, share counts, dates, and dollar figures without an explicit payee description.